Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

MAY 1, 2022

A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. Cannabis is no longer a one-size-fits-all industry,” Gary Allen, CEO of New Frontier Data, said in a statement.

Data 52

Data Legalization Consumption Collective 52

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

CannaMD

SEPTEMBER 15, 2020

What law legalized medical marijuana in Florida? How does Florida law define medical marijuana? SHORT ANSWER: Low-THC cannabis , defined by Florida law, only contains 8% or less THC and more than 10% CBD. SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. Crohn’s Disease.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

NOVEMBER 14, 2019

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write.

Conditions 45

Conditions Data Medicine Collective 45

Cannabis Law Report

FEBRUARY 23, 2022

Provides a conditional adult-use cultivator license to process and distribute cannabis flower products without holding an adult-use processor or distributor license; provides a conditional adult-use processor license to process and distribute cannabis products; provides for the repeal of certain provisions upon the expiration thereof.

Legislation 105

Legislation Conditions Cultivation Agriculture 105

Cannabis Law Report

NOVEMBER 19, 2019

(CSE:GRIN | OTC: GRUSF) (“ Grown Rogue ” or the “ Company ”), a vertically-integrated, multi-state cannabis company, with operations and assets in Oregon, California, and Michigan, has released survey data suggesting the pricing in the Oregon cannabis market is recovering. . Survey Highlights.

Data 45

Data Dispensary Retail Recreational 45

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Under what conditions can the deal be terminated? Which jurisdiction does the company insist upon for agreement law? Access Psychiatry deal headline, upfront, milestone and royalty data. Trends in Psychiatry dealmaking in the biopharma industry since 2014.

Access 52

Access Data Pharmaceutical Research and Development 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

JULY 11, 2022

Gavin Newsom signed budget trailer bill Assembly Bill 195 (AB-195) into law. AB-195 contains several significant reforms to California’s cannabis laws. Delivery Data Required to be Reported in Metrc. Another noteworthy change is that retail delivery data will be required to be entered into Metrc by January 1, 2023.

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Canna Law Blog

SEPTEMBER 24, 2022

Given the expansive and stratified plans for New York’s adult-use cannabis industry (with the general ban on vertical integration, emphasis on social equity and advanced conditional licenses), the Director of Policy will have a quite a few responsibilities. First, the OCM clearly was looking for someone with a background in data analytics.

Policy 72

Policy Research and Development Data Legislation 72

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JUNE 27, 2023

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

Research and Development 104

Research and Development Data Collective Vaping 104

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Alzheimer’s disease impacts about 50 million people worldwide and about 5.5 million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

JUNE 23, 2021

RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Programs 100

Programs Data Events Collective 100

Canna Law Blog

AUGUST 2, 2023

We wrote about this rule not long after noting that aspergillus—a type of mold that can cause a skin cause a condition called aspergillosis when inhaled or introduced through a cut in your skin. Early data reflected fail rates ranging from 2.7% – 20% depending on the number of variants subject to testing.

Data 72

Data Conditions Cannabis Law 72

Veriheal

JULY 25, 2023

are increasingly relaxing their cannabis laws, it’s no surprise that the drug’s consumption has grown , especially among American workers. Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. As many states across the U.S.

Safety 95

Safety Data Recreational Marijuana 95

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Veriheal

DECEMBER 14, 2023

The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronic pain, anxiety, and insomnia. Having a medical marijuana card can help with a wide range of physical and mental health disorders, and laws are changing frequently to allow them in more and more states.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

The Cannigma

JUNE 30, 2021

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% The most common medical conditions. In Colorado, 78.7%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. 1 Of course, this risk was more intense for some than for others.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

JUNE 5, 2021

” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. Why does Argentina have the conditions to be an important producer in the cannabis and hemp industry? ” What benefits would the approval of this hemp and cannabis law bring to Argentina?

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Veriheal

MAY 19, 2023

SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. The case report built off data self-study complied by an Institute colleague and combined it with past reports of colorblind individuals who experienced vision improvements after consuming psilocybin.

Chronic Pain 97

Chronic Pain Data Consumption Safety 97

Cannabis Law Report

AUGUST 5, 2019

Ojai Energetics initiated and co-sponsored the legislation signed by Governor Jerry Brown of California that pushed hemp legislation SB 1409 into law, a move that significantly expanded hemp farming in California. Read more. . USA Today Report: Cannabis Consumers Reduce Use of Pills, Booze. . Read more. . More Kroger Co.

Law 40

Law Decriminalization Hemp Legislation 40

Cannabis Law Report

FEBRUARY 26, 2019

Long Beach Business Journal reports… The Long Beach Planning Commission on February 21 approved a conditional use permit for a facility to grow, test and distribute recreational cannabis in an industrial area on 15th Street, between Oregon and San Francisco avenues.

Recreational 45

Recreational Conditions Research and Development Cultivation 45